Vyro Bio

Sao Paulo, Brazil Founded: 2021 • Age: 5 yrs
Oncolytic virus drugs are developed for central nervous system tumors.

About Vyro Bio

Vyro Bio is a Healthcare company based in Sao Paulo (Brazil) founded in 2021 by Hugo Cabrera. Oncolytic virus drugs are developed for central nervous system tumors. Vyro Bio offers products and services including Zika Virus Treatment and Viral-based Therapeutics. Its focus areas include Life Sciences, Oncology, Drugs and Diversified.

Company details

Founded in 2021 in Sao Paulo, Brazil, therapeutics based on Zika virus are developed by Vyro Bio to target cancer cells and malignant tumors in the adult and pediatric central nervous system. Operations are conducted within the biotechnology sector, with emphasis on oncolytic viruses for oncology applications. The companys activities center on advancing treatments for CNS-related cancers through innovative viral mechanisms.

Operational Areas

Products & Services of Vyro Bio

Vyro Bio offers a comprehensive portfolio of products and services, including Zika Virus Treatment and Viral-based Therapeutics.

Zika Virus Treatment
Biotech Therapy

Develops treatments using modified viruses to address health issues like Zika.

Viral-based Therapeutics
Health Solutions

Creates engineered virus treatments for revolutionary medical applications.

Apps and channels of Vyro Bio

its YouTube channel VYRO has 10 subscribers and 1 videos.

VYRO
YouTube 10 subscribers 1 videos Health & Fitness
Open channel

Videos from Vyro Bio

The most watched videos on Vyro Bio's YouTube channel, VYRO (10 subscribers). Click a video to play it here.

A ORIGEM DA VYRO
73 views

More on VYRO.

People of Vyro Bio

9 people are tracked at Vyro Bio (1 in leadership, 7 in board & advisors, 1 in team).

NameRoleGroup
Hugo Cabrera
Co-FounderLeadership
Marcia De Souza Lima
Scientific AdvisorBoard & advisors
Caroline Chaul
Medical AdvisorBoard & advisors
Ernesto Goulart
Co-FounderBoard & advisors
Mayana Zatz
Co-founder & Scientific AdvisorBoard & advisors
Keith Okamoto
Cofounder & Board MemberBoard & advisors
Harry Bulstrode
Scientific AdvisorBoard & advisors
Jorge Kalil
Board MemberBoard & advisors
Flávia Santoro
Marketing AssistantTeam
Premium access

Complete people profiles for Vyro Bio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Web traffic of Vyro Bio

The website of Vyro Bio (vyrobio.com) receives about 3.3K visits a month.

  • Monthly visits
    3.3K

    ▲ 58.3% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Vyro Bio

Vyro Bio was founded in 2021.

Vyro Bio is headquartered in Sao Paulo, Brazil.

Founded in 2021 in Sao Paulo, Brazil, therapeutics based on Zika virus are developed by Vyro Bio to target cancer cells and malignant tumors in the adult and pediatric central nervous system. Operations are conducted within the biotechnology sector, with emphasis on oncolytic viruses for oncology applications. The companys activities center on advancing treatments for CNS-related cancers through innovative viral mechanisms.

Vyro Bio offers Zika Virus Treatment and Viral-based Therapeutics.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available